Millennium Management
AURA icon

Millennium Management’s Aura Biosciences AURA Stock Holding History

Millennium Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.34M Buy
1,097,627
+480,289
+78% +$2.76M ﹤0.01% 2511
2025
Q4 		$3.36M Buy
617,338
+432,117
+233% +$2.57M ﹤0.01% 3432
2025
Q3 		$1.14M Buy
185,221
+61,162
+49% +$400K ﹤0.01% 4521
2025
Q2 		$777K Buy
+124,059
New +$726K ﹤0.01% 4600
2024
Q3 		– Sell
-22,188
Closed -$168K – 6081
2024
Q2 		$168K Sell
22,188
-48,529
-69% -$355K ﹤0.01% 5196
2024
Q1 		$555K Buy
+70,717
New +$586K ﹤0.01% 4745
2023
Q2 		– Sell
-31,281
Closed -$290K – 6095
2023
Q1 		$290K Buy
+31,281
New +$325K ﹤0.01% 4926
2022
Q3 		– Sell
-22,917
Closed -$325K – 7047
2022
Q2 		$325K Buy
+22,917
New +$379K ﹤0.01% 5297

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management's AURA Position: Q1 2026 in Review

Millennium Management increased its Aura Biosciences (AURA) stake by 78% in Q1 2026, buying an estimated $2.76M and bringing the position to 1,097,627 shares worth $7.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Millennium Management first reported a position in AURA in Q2 2022 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Millennium Management held 1,097,627 shares of Aura Biosciences worth $7.34M as of Q1 2026.
  • Millennium Management bought 480,289 Aura Biosciences shares in Q1 2026, an estimated $2.76M.
  • Aura Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2511 holding.
  • Millennium Management first reported a position in Aura Biosciences in Q2 2022 and has held it in 8 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.